A phase II placebo-controlled study of tralokinumab in moderate-to-severe asthma - Piper, E; Brightling, C; Niven, R; Oh, C; Faggioni, R; Poon, K; She, D; Kell, C; May, R D; Geba, G Pand all (Eur Respir J, 2013)